Persistence of the Immune Responses and Cross-Neutralizing Activity With Variants of Concern Following 2 Doses of Adjuvanted SCB-2019 Coronavirus Disease 2019 Vaccine - Concepedia

Concepedia

Publication | Open Access

Persistence of the Immune Responses and Cross-Neutralizing Activity With Variants of Concern Following 2 Doses of Adjuvanted SCB-2019 Coronavirus Disease 2019 Vaccine

DOI Full Paper Access

17

Citations

17

References

2021

Year

Peter Richmond, Lara Hatchuel, Filippo Pacciarini, Branda Hu, Igor Smolenov, Ping Li, Peng Liang, Htay Htay Han, Joshua G. Liang, Ralf Clemens

The Journal of Infectious Diseases

Abstract

SCB-2019 dose-dependently induced immune responses against wild-type SARS-CoV-2, which persisted up to day 184. Neutralizing antibodies were cross-reactive against 3 of the most prevalent VoCs.

References

	Year	Citations

Page 1